Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline. Poor solubility and low bioavailability have hindered the development pipeline ...

In the development of new pharmaceutical ingredients and other high-purity products, carefully controlled crystallization ...